Closes Oct 8, 2027
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Open federal grants available in West Virginia
Currently open U.S. federal opportunities that West Virginia applicants can apply for, including nationwide programs. Sorted by closing date. Applications are submitted on Grants.gov.
1,449 open opportunities
Closes Oct 8, 2027
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 12, 2027Up to $500K
NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 13, 2027From $600K
Research Experiences for Teachers (RET) in Engineering and Computer Science
- Agency
- U.S. National Science Foundation
- Eligible locations
- Nationwide
Closes Oct 14, 2027
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 14, 2027
NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 15, 2027
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 15, 2027
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 15, 2027
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 15, 2027
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 15, 2027
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 15, 2027
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 15, 2027
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 15, 2027From $110K
NSF Astronomy and Astrophysics Postdoctoral Fellowships (AAPF)
- Agency
- U.S. National Science Foundation
- Eligible locations
- Nationwide
Closes Oct 15, 2027
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 15, 2027
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 15, 2027
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 16, 2027
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 18, 2027
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 19, 2027$50K – $300K
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 19, 2027Up to $650K
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 20, 2027Up to $750K
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 20, 2027Up to $750K
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 20, 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 25, 2027
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide